Federal prosecutors in Manhattan brought Francisco Alberto Lopez Reyes and Edward Eustate Jimenez to trial in the Southern District of New York on charges arising from an alleged counterfeit pharmaceutical operation that routed fentanyl-laced pills to buyers across all 50 states [1]. The government charged Lopez Reyes as the principal administrator of a continuing criminal enterprise, alongside counts of conspiracy to distribute narcotics resulting in death, narcotics distribution, and conspiracy to commit money laundering [1]. Jimenez faced narcotics conspiracy and distribution counts [1]. The case proceeded to a jury after a six-week trial before Judge John P. Cronan [1].
The jury returned guilty verdicts against both defendants on June 1, 2026 [1]. According to the government, the enterprise distributed more than one million counterfeit pills, manufactured to resemble legitimate pharmaceuticals but laced with fentanyl, through fake online pharmacies operating as the distribution infrastructure [1]. The scheme reached customers in every state and caused at least one death, which elevated the narcotics conspiracy charge to the death-resulting tier [1]. Lopez Reyes was convicted on all four counts, including the continuing criminal enterprise count, which carries a mandatory minimum sentence of 20 years and a statutory maximum of life [1]. Jimenez was convicted on the narcotics conspiracy and distribution counts [1].
No sentencing date has been publicly announced [1]. The continuing criminal enterprise conviction alone exposes Lopez Reyes to a life sentence, and the death-resulting narcotics conspiracy count carries its own mandatory sentencing floor [1]. The government has characterized the prosecution as one of the largest counterfeit pharmaceutical distribution cases in SDNY history [1].
No post-trial motions or notice of appeal appeared in the publicly available record as of the verdict date. Given the breadth of the conviction, including the kingpin-statute count, any appeal is likely to focus on the sufficiency of the enterprise evidence and the scope of the death-nexus instruction. Sentencing proceedings will determine whether the court imposes consecutive or concurrent terms across the multiple counts of conviction [1].